2022 UPMC Heart and Vascular Institute Heart Valve Symposium: Aortic Valve Disease Section
June 22, 2022
The UPMC Heart and Vascular Institute Heart Valve Symposium is an annual CME-accredited symposium featuring a range of discussions about the latest advancements in diagnosis, treatment, and management for patients with complex valve and structural heart disease. The 2022 symposium included in-depth discussions about transcatheter aortic valve replacement (TAVR), the future of surgical aortic valve replacement, mitral and tricuspid valve disease, minimally invasive and robotic cardiac surgery, and more.
View the presentations focusing on aortic valve disease here.
For more information or to refer a patient, please email HVIReferral@upmc.edu.
Section 1: Aortic Valve Disease: Moderated by A.J. Conrad Smith, MD
- TAVR in the low-risk patient population – Are we there yet?
- Role of advanced imaging in heart valve disease
- Valve selection in TAVR – How do I decide?
- Percutaneous coronary interventions with TAVR – Tips and tricks
- The challenging TAVR: Approach and considerations
- Surgical aortic valve replacement – What does the future look like?
You can view the Mitral and Tricuspid Valve Disease session presentations here and the Structural Heart Disease session presentations here.
